Holen Sie sich die Stockscreener-App
0.00
100.00%
-4.02
Schlusskurs vom Vortag:
$4.02
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$4.37M
Einnahmen:
$3.29M
Nettoeinkommen (Verlust:
$-3.09M
KGV:
0.00
EPS:
-1.23
Netto-Cashflow:
$-2.46M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$161.00
Nanovibronix Inc Stock (NAOV) Company Profile
Firmenname
Nanovibronix Inc
Sektor
Branche
Telefon
(914) 233-3004
Adresse
969 PRUITT AVE,, TYLER
Vergleichen Sie NAOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.00 | 4.37M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
107.42 | 188.86B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
92.51 | 135.38B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.04 | 137.16B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.88 | 129.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.66 | 49.00B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nanovibronix Inc Aktie (NAOV) Neueste Nachrichten
Targets Report: Is Groupon Inc in a bullish channel2025 Investor Takeaways & AI Forecast Swing Trade Picks - baoquankhu1.vn
IPO Launch: Is NanoVibronix Inc a potential multi baggerJuly 2025 Update & Expert-Curated Trade Recommendations - baoquankhu1.vn
Targets Report: How does SGMO perform in inflationary periods2025 Top Decliners & Target Return Focused Picks - baoquankhu1.vn
Aug Update: Can OXYWS disrupt its industryJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Can NanoVibronix Inc. stock sustain revenue growth2025 Risk Factors & Breakout Confirmation Trade Signals - Улправда
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research - The Manila Times
ENvue Medical Launches Program to Address Patient Pain and - GlobeNewswire
New program targets pain from nasogastric tubes left in for days - Stock Titan
Why NanoVibronix Inc. stock is seen as undervaluedJuly 2025 Momentum & AI Based Buy and Sell Signals - Улправда
Why NanoVibronix Inc. stock could outperform in 2025July 2025 Recap & Trade Opportunity Analysis Reports - Улправда
Is NanoVibronix Inc. (56R) stock a top pick for value investors2025 Performance Recap & Free Community Consensus Stock Picks - ulpravda.ru
Can NanoVibronix Inc. (56R) stock deliver strong annual returns2025 Short Interest & Community Verified Watchlist Alerts - Улправда
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 - GlobeNewswire
How analysts revise price targets for NanoVibronix Inc. (56R) stockJuly 2025 Levels & Fast Entry and Exit Trade Plans - Улправда
Will NanoVibronix Inc. (56R) stock beat international competitionHigh Beta Stocks & Invest Now – Opportunity Window Closing - Улправда
Envue Medical amends long term incentive plan to align with Israeli tax laws - Investing.com
ENvue Medical, Inc.Common Stock (NQ: NAOV - FinancialContent
Short Covering: Will NanoVibronix Inc stock continue dividend increases2025 Winners & Losers & High Conviction Buy Zone Alerts - moha.gov.vn
Market Outlook: Is CANF stock a top momentum playTrade Exit Summary & Daily Chart Pattern Signals - moha.gov.vn
Can NanoVibronix Inc. stock hit analyst price targets2025 Institutional Moves & Technical Pattern Recognition Alerts - Улправда
Will NanoVibronix Inc. stock continue dividend increases2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - Bölüm Sonu Canavarı
Decliners Report: Is NanoVibronix Inc. stock a dividend growth opportunity2025 Stock Rankings & Entry Point Confirmation Alerts - moha.gov.vn
Why NanoVibronix Inc. stock appeals to analystsTreasury Yields & Technical Entry and Exit Alerts - Улправда
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK - The Manila Times
[Form 3] NanoVibronix, Inc. Initial Statement of Beneficial Ownership - Stock Titan
ENvue Medical, Inc. (NAOV) director reports no beneficial ownership on Form 3 - Stock Titan
ENvue Medical (Nasdaq: FEED) details 7.96M-share resale, Series H terms - Stock Titan
Bond Watch: Will NanoVibronix Inc. (56R) stock beat international competitionSwing Trade & Free AI Powered Buy and Sell Recommendations - Улправда
UK adds ENvue Medical’s UroShield kit to NHS drug tariff - Investing.com
UK adds ENvue Medical’s UroShield kit to NHS drug tariff By Investing.com - Investing.com Australia
UK patients with long-term catheters gain NHS-backed access to new device - Stock Titan
ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK - marketscreener.com
NHS to cover new device designed to cut catheter infections in the UK - Stock Titan
NanoVibronix to change name, symbol - MSN
Envue Medical appoints veteran David Johnson as chairman - marketscreener.com
NanoVibronix Earnings Notes - Trefis
ENvue Medical Inc (FEED) Stock Earnings Transcripts - GuruFocus
ENvue Medical, Inc.: Shareholders Board Members Managers and Company Profile | US63008J8844 - marketscreener.com
News On NanoVibronix Inc. (NAOV) Now Under FEED - 富途牛牛
NanoVibronix rebrands to ENvue Medical, updates ticker - MSN
ENvue Medical, Inc. has Changed its Ticker to FEED from NAOV - marketscreener.com
NanoVibronix, Inc. has Changed its Name to ENvue Medical, Inc - marketscreener.com
NanoVibronix Rebrands to ENvue Medical, Updates Ticker - TipRanks
NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol - Investing.com
NanoVibronix to Rebrand as ENvue Medical, Ticker to Change to FE - GuruFocus
NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol By Investing.com - Investing.com Australia
NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’ - marketscreener.com
NanoVibronix to Become ENvue Medical (NASDAQ: FEED) as New Ticker Starts Trading - Stock Titan
Rate Hike: Why NanoVibronix Inc stock is seen as undervaluedJuly 2025 Closing Moves & Short-Term High Return Ideas - moha.gov.vn
Is NanoVibronix Inc a good long term investmentChart Pattern Recognition & Access Free Risk Analysis Before You Invest - earlytimes.in
Would You Still Hold NanoVibronix Stock If It Fell Another 30%? - Trefis
Finanzdaten der Nanovibronix Inc-Aktie (NAOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):